Filippo Marmont

2.5k total citations
46 papers, 1.5k citations indexed

About

Filippo Marmont is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Filippo Marmont has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 19 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Filippo Marmont's work include Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (16 papers) and Acute Lymphoblastic Leukemia research (10 papers). Filippo Marmont is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Multiple Myeloma Research and Treatments (16 papers) and Acute Lymphoblastic Leukemia research (10 papers). Filippo Marmont collaborates with scholars based in Italy, United States and Brazil. Filippo Marmont's co-authors include Mario Boccadoro, M Tribalto, Franco Mandelli, Michele Falda, Giuseppe Avvisati, Sergio Amadori, Alessandro Pileri, Franco Dammacco, Alessandro Busca and Franco Locatelli and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Filippo Marmont

46 papers receiving 1.5k citations

Peers

Filippo Marmont

HEMAT

ONCOL

GENET

PHEOH

K. B. McCredie United States

J. A. Liu Yin United Kingdom

G. L. Phillips Canada

Hyun‐Sook Chi South Korea

T. de Witte Netherlands

DJ Weisdorf United States

Francesco Nobile Italy

Gunnar Grimfors Sweden

J Cahn France

Appelbaum Fr United States

K. B. McCredie United States

Filippo Marmont

1.1k ×1.0

HEMAT

329 ×0.6

444 ×0.9

ONCOL

439 ×1.5

GENET

432 ×1.8

PHEOH

Citations per year, relative to Filippo Marmont Filippo Marmont (= 1×) peers K. B. McCredie

Countries citing papers authored by Filippo Marmont

Since Specialization

Citations

This map shows the geographic impact of Filippo Marmont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filippo Marmont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filippo Marmont more than expected).

Fields of papers citing papers by Filippo Marmont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filippo Marmont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filippo Marmont. The network helps show where Filippo Marmont may publish in the future.

Co-authorship network of co-authors of Filippo Marmont

This figure shows the co-authorship network connecting the top 25 collaborators of Filippo Marmont. A scholar is included among the top collaborators of Filippo Marmont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filippo Marmont. Filippo Marmont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Frairia, Chiara, Semra Aydin, Ernesta Audisio, et al.. (2017). Post-remissional and pre-transplant role of minimal residual disease detected by WT1 in acute myeloid leukemia: A retrospective cohort study. Leukemia Research. 61. 10–17. 19 indexed citations

Ferrero, Dario, Elena Crisà, Filippo Marmont, et al.. (2014). Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents. Annals of Hematology. 93(8). 1391–1400. 20 indexed citations

Riera, Ludovica, Filippo Marmont, Chiara Frairia, et al.. (2013). Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncology Reports. 29(5). 1867–1872. 33 indexed citations

Busca, Alessandro, Clara Pecoraro, Luisa Giaccone, et al.. (2013). Allogeneic stem cell transplant for adults with myelodysplastic syndromes: relevance of pre-transplant disease status. Leukemia & lymphoma. 55(4). 863–869. 4 indexed citations

Riera, Ludovica, Elena Lasorsa, Lisa Bonello, et al.. (2011). Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects. Leukemia & lymphoma. 52(9). 1742–1750. 11 indexed citations

Busca, Alessandro, Franco Locatelli, Stefano D’Ardìa, et al.. (2011). Blood stream infections after allogeneic stem cell transplantation: a single‐center experience with the use of levofloxacin prophylaxis. Transplant Infectious Disease. 14(1). 40–48. 38 indexed citations

Squadrone, Vincenzo, Massimo Massaia, Benedetto Bruno, et al.. (2010). Early CPAP prevents evolution of acute lung injury in patients with hematologic malignancy. Intensive Care Medicine. 36(10). 1666–1674. 95 indexed citations

Pulsoni, Alessandro, Livio Pagano, Roberto Latagliata, et al.. (2004). Survival of elderly patients with acute myeloid leukemia.. PubMed. 89(3). 296–302. 49 indexed citations

Camera, Andrea, Luciana Annino, Federico Chiurazzi, et al.. (2004). GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia.. PubMed. 89(2). 145–53. 26 indexed citations

10.

Scaravaglio, Patrizia, Tommasina Guglielmelli, Emilia Giugliano, et al.. (2002). Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation. Cancer Genetics and Cytogenetics. 133(1). 98–101. 6 indexed citations

11.

Guerrasio, Angelo, Daniela De Micheli, Anna Serra, et al.. (2002). Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. Leukemia. 16(6). 1176–1181. 77 indexed citations

12.

Boccadoro, Mario, Antonio Palumbo, Alida Dominietto, et al.. (1997). Conventional induction treatments do not influence overall survival in multiple myeloma. British Journal of Haematology. 96(2). 333–337. 16 indexed citations

13.

Marmont, Filippo, Achille Pich, Luigi Chiusa, et al.. (1996). Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma. European Journal Of Haematology. 56(1-2). 39–44. 4 indexed citations

14.

Pich, Achille, Luigi Chiusa, Mario Boccadoro, & Filippo Marmont. (1994). AgNORs and Myeloma Prognosis. Leukemia & lymphoma. 12(5-6). 383–394. 8 indexed citations

15.

Pich, Achille, Luigi Chiusa, Filippo Marmont, N Cappello, & R Navone. (1992). Argyrophilic nucleolar organizer region counts in multiple myeloma: A histopathological study on bone marrow trephine biopsies. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 421(2). 143–147. 14 indexed citations

16.

Boccadoro, Mario, Filippo Marmont, M Tribalto, et al.. (1991). Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients.. Journal of Clinical Oncology. 9(3). 444–448. 92 indexed citations

17.

Silvestro, Luigi, et al.. (1991). Quantitation of melphalan in plasma of patients by reversed-phase high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 563(2). 443–450. 16 indexed citations

18.

Mandelli, Franco, Giuseppe Avvisati, Sergio Amadori, et al.. (1990). Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy. New England Journal of Medicine. 322(20). 1430–1434. 296 indexed citations

19.

Boccadoro, Mario, Filippo Marmont, M Tribalto, et al.. (1989). Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis.. Journal of Clinical Oncology. 7(1). 119–125. 58 indexed citations

20.

Mandelli, Franco, M Tribalto, Giuseppe Avvisati, et al.. (1988). Recombinant interferon alfa-2b (INTRON A) as post-induction therapy for responding multiple myeloma patients. M84 protocol. Cancer Treatment Reviews. 15. 43–48. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact